Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence.

Koratala A, Kazory A.

Dis Markers. 2017;2017:1454986. doi: 10.1155/2017/1454986. Epub 2017 Jun 18. Review.

2.

BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.

Khalid U, Wruck LM, Quibrera PM, Bozkurt B, Nambi V, Virani SS, Jneid H, Agarwal S, Chang PP, Loehr L, Basra SS, Rosamond W, Ballantyne CM, Deswal A.

Int J Cardiol. 2017 Apr 15;233:61-66. doi: 10.1016/j.ijcard.2017.01.130. Epub 2017 Jan 31.

PMID:
28185703
3.

Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.

Todorova VK, Makhoul I, Siegel ER, Wei J, Stone A, Carter W, Beggs ML, Owen A, Klimberg VS.

PLoS One. 2016 Aug 4;11(8):e0160224. doi: 10.1371/journal.pone.0160224. eCollection 2016.

4.

Randomized Controlled Trial of Individualized Dialysate Cooling for Cardiac Protection in Hemodialysis Patients.

Odudu A, Eldehni MT, McCann GP, McIntyre CW.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1408-17. doi: 10.2215/CJN.00200115. Epub 2015 May 11.

5.

The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis.

Nakagawa Y, Nishikimi T, Kuwahara K, Yasuno S, Kinoshita H, Kuwabara Y, Nakao K, Minami T, Yamada C, Ueshima K, Ikeda Y, Okamoto H, Horii K, Nagata K, Kangawa K, Minamino N, Nakao K.

PLoS One. 2014 Mar 25;9(3):e92314. doi: 10.1371/journal.pone.0092314. eCollection 2014.

6.

B-type natriuretic peptide is not a volume marker among patients on hemodialysis.

Agarwal R.

Nephrol Dial Transplant. 2013 Dec;28(12):3082-9. doi: 10.1093/ndt/gft054. Epub 2013 Mar 22.

7.
8.

Plasma Brain Natriuretic Peptide Levels in Cardiac Function Assessment in Chronic Dialysis Patients.

Sanjuan R, Oliva SM, Blasco ML, Puchades M, Torregrosa I, Ramón RG, Carrasco AM.

Cardiorenal Med. 2011;1(3):147-155. Epub 2011 Jul 1.

9.

Biomarkers in predicting mortality and treatment in hemodialysis patients.

Wang AY.

F1000 Med Rep. 2009 Mar 17;1. pii: 21. doi: 10.3410/M1-21.

10.

N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?

Booth J, Pinney J, Davenport A.

Clin J Am Soc Nephrol. 2010 Jun;5(6):1036-40. doi: 10.2215/CJN.09001209. Epub 2010 May 27.

11.

Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial.

Paniagua R, Amato D, Mujais S, Vonesh E, Ramos A, Correa-Rotter R, Horl WH.

Clin J Am Soc Nephrol. 2008 Mar;3(2):407-15. doi: 10.2215/CJN.03820907. Epub 2008 Jan 16.

Supplemental Content

Support Center